List of Tables
Table 1. Global Antibody-drug Conjugates for Tumors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Antibody-drug Conjugates for Tumors Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Antibody-drug Conjugates for Tumors Market Competitive Situation by Manufacturers in 2023
Table 4. Global Antibody-drug Conjugates for Tumors Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Antibody-drug Conjugates for Tumors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Antibody-drug Conjugates for Tumors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Antibody-drug Conjugates for Tumors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Antibody-drug Conjugates for Tumors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Antibody-drug Conjugates for Tumors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antibody-drug Conjugates for Tumors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antibody-drug Conjugates for Tumors, Product Type & Application
Table 12. Global Key Manufacturers of Antibody-drug Conjugates for Tumors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antibody-drug Conjugates for Tumors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates for Tumors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antibody-drug Conjugates for Tumors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Antibody-drug Conjugates for Tumors Sales by Region (2019-2024) & (K Units)
Table 18. Global Antibody-drug Conjugates for Tumors Sales Market Share by Region (2019-2024)
Table 19. Global Antibody-drug Conjugates for Tumors Sales by Region (2025-2030) & (K Units)
Table 20. Global Antibody-drug Conjugates for Tumors Sales Market Share by Region (2025-2030)
Table 21. Global Antibody-drug Conjugates for Tumors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Antibody-drug Conjugates for Tumors Revenue Market Share by Region (2019-2024)
Table 23. Global Antibody-drug Conjugates for Tumors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Antibody-drug Conjugates for Tumors Revenue Market Share by Region (2025-2030)
Table 25. North America Antibody-drug Conjugates for Tumors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Antibody-drug Conjugates for Tumors Sales by Country (2019-2024) & (K Units)
Table 27. North America Antibody-drug Conjugates for Tumors Sales by Country (2025-2030) & (K Units)
Table 28. North America Antibody-drug Conjugates for Tumors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Antibody-drug Conjugates for Tumors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Antibody-drug Conjugates for Tumors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Antibody-drug Conjugates for Tumors Sales by Country (2019-2024) & (K Units)
Table 32. Europe Antibody-drug Conjugates for Tumors Sales by Country (2025-2030) & (K Units)
Table 33. Europe Antibody-drug Conjugates for Tumors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Antibody-drug Conjugates for Tumors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Antibody-drug Conjugates for Tumors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Antibody-drug Conjugates for Tumors Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Antibody-drug Conjugates for Tumors Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Antibody-drug Conjugates for Tumors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Antibody-drug Conjugates for Tumors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antibody-drug Conjugates for Tumors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Antibody-drug Conjugates for Tumors Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Antibody-drug Conjugates for Tumors Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Antibody-drug Conjugates for Tumors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antibody-drug Conjugates for Tumors Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Antibody-drug Conjugates for Tumors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Antibody-drug Conjugates for Tumors Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Antibody-drug Conjugates for Tumors Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Antibody-drug Conjugates for Tumors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Antibody-drug Conjugates for Tumors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Antibody-drug Conjugates for Tumors Sales (K Units) by Type (2019-2024)
Table 51. Global Antibody-drug Conjugates for Tumors Sales (K Units) by Type (2025-2030)
Table 52. Global Antibody-drug Conjugates for Tumors Sales Market Share by Type (2019-2024)
Table 53. Global Antibody-drug Conjugates for Tumors Sales Market Share by Type (2025-2030)
Table 54. Global Antibody-drug Conjugates for Tumors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Antibody-drug Conjugates for Tumors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Antibody-drug Conjugates for Tumors Revenue Market Share by Type (2019-2024)
Table 57. Global Antibody-drug Conjugates for Tumors Revenue Market Share by Type (2025-2030)
Table 58. Global Antibody-drug Conjugates for Tumors Price (US$/Unit) by Type (2019-2024)
Table 59. Global Antibody-drug Conjugates for Tumors Price (US$/Unit) by Type (2025-2030)
Table 60. Global Antibody-drug Conjugates for Tumors Sales (K Units) by Application (2019-2024)
Table 61. Global Antibody-drug Conjugates for Tumors Sales (K Units) by Application (2025-2030)
Table 62. Global Antibody-drug Conjugates for Tumors Sales Market Share by Application (2019-2024)
Table 63. Global Antibody-drug Conjugates for Tumors Sales Market Share by Application (2025-2030)
Table 64. Global Antibody-drug Conjugates for Tumors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Antibody-drug Conjugates for Tumors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Antibody-drug Conjugates for Tumors Revenue Market Share by Application (2019-2024)
Table 67. Global Antibody-drug Conjugates for Tumors Revenue Market Share by Application (2025-2030)
Table 68. Global Antibody-drug Conjugates for Tumors Price (US$/Unit) by Application (2019-2024)
Table 69. Global Antibody-drug Conjugates for Tumors Price (US$/Unit) by Application (2025-2030)
Table 70. Roche（Genentech） Company Information
Table 71. Roche（Genentech） Description and Business Overview
Table 72. Roche（Genentech） Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche（Genentech） Antibody-drug Conjugates for Tumors Product
Table 74. Roche（Genentech） Recent Developments/Updates
Table 75. Daiichi Sankyo Company Information
Table 76. Daiichi Sankyo Description and Business Overview
Table 77. Daiichi Sankyo Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Daiichi Sankyo Antibody-drug Conjugates for Tumors Product
Table 79. Daiichi Sankyo Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GSK Antibody-drug Conjugates for Tumors Product
Table 84. GSK Recent Developments/Updates
Table 85. Rakuten Medical Company Information
Table 86. Rakuten Medical Description and Business Overview
Table 87. Rakuten Medical Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Rakuten Medical Antibody-drug Conjugates for Tumors Product
Table 89. Rakuten Medical Recent Developments/Updates
Table 90. ADC Therapeutics Company Information
Table 91. ADC Therapeutics Description and Business Overview
Table 92. ADC Therapeutics Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. ADC Therapeutics Antibody-drug Conjugates for Tumors Product
Table 94. ADC Therapeutics Recent Developments/Updates
Table 95. RemeGen Company Information
Table 96. RemeGen Description and Business Overview
Table 97. RemeGen Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. RemeGen Antibody-drug Conjugates for Tumors Product
Table 99. RemeGen Recent Developments/Updates
Table 100. AbbVie(ImmunoGen) Company Information
Table 101. AbbVie(ImmunoGen) Description and Business Overview
Table 102. AbbVie(ImmunoGen) Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. AbbVie(ImmunoGen) Antibody-drug Conjugates for Tumors Product
Table 104. AbbVie(ImmunoGen) Recent Developments/Updates
Table 105. Pfizer（Seagen) Company Information
Table 106. Pfizer（Seagen) Description and Business Overview
Table 107. Pfizer（Seagen) Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer（Seagen) Antibody-drug Conjugates for Tumors Product
Table 109. Pfizer（Seagen) Recent Developments/Updates
Table 110. Takeda Company Information
Table 111. Takeda Description and Business Overview
Table 112. Takeda Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Takeda Antibody-drug Conjugates for Tumors Product
Table 114. Takeda Recent Developments/Updates
Table 115. Gilead Sciences Company Information
Table 116. Gilead Sciences Description and Business Overview
Table 117. Gilead Sciences Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Gilead Sciences Antibody-drug Conjugates for Tumors Product
Table 119. Gilead Sciences Recent Developments/Updates
Table 120. AstraZeneca Company Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Antibody-drug Conjugates for Tumors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. AstraZeneca Antibody-drug Conjugates for Tumors Product
Table 124. AstraZeneca Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Antibody-drug Conjugates for Tumors Distributors List
Table 128. Antibody-drug Conjugates for Tumors Customers List
Table 129. Antibody-drug Conjugates for Tumors Market Trends
Table 130. Antibody-drug Conjugates for Tumors Market Drivers
Table 131. Antibody-drug Conjugates for Tumors Market Challenges
Table 132. Antibody-drug Conjugates for Tumors Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antibody-drug Conjugates for Tumors
Figure 2. Global Antibody-drug Conjugates for Tumors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Antibody-drug Conjugates for Tumors Market Share by Type: 2023 & 2030
Figure 4. DNA Damaging Drugs Product Picture
Figure 5. Tubulin Inhibitors Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antibody-drug Conjugates for Tumors Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Antibody-drug Conjugates for Tumors Market Share by Application: 2023 & 2030
Figure 9. Hematological Tumors
Figure 10. Solid Tumors
Figure 11. Global Antibody-drug Conjugates for Tumors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Antibody-drug Conjugates for Tumors Market Size (2019-2030) & (US$ Million)
Figure 13. Global Antibody-drug Conjugates for Tumors Sales (2019-2030) & (K Units)
Figure 14. Global Antibody-drug Conjugates for Tumors Average Price (US$/Unit) & (2019-2030)
Figure 15. Antibody-drug Conjugates for Tumors Report Years Considered
Figure 16. Antibody-drug Conjugates for Tumors Sales Share by Manufacturers in 2023
Figure 17. Global Antibody-drug Conjugates for Tumors Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Antibody-drug Conjugates for Tumors Players: Market Share by Revenue in Antibody-drug Conjugates for Tumors in 2023
Figure 19. Antibody-drug Conjugates for Tumors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Antibody-drug Conjugates for Tumors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Antibody-drug Conjugates for Tumors Sales Market Share by Country (2019-2030)
Figure 22. North America Antibody-drug Conjugates for Tumors Revenue Market Share by Country (2019-2030)
Figure 23. United States Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Antibody-drug Conjugates for Tumors Sales Market Share by Country (2019-2030)
Figure 26. Europe Antibody-drug Conjugates for Tumors Revenue Market Share by Country (2019-2030)
Figure 27. Germany Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Antibody-drug Conjugates for Tumors Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Antibody-drug Conjugates for Tumors Revenue Market Share by Region (2019-2030)
Figure 34. China Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Antibody-drug Conjugates for Tumors Sales Market Share by Country (2019-2030)
Figure 42. Mexico Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Antibody-drug Conjugates for Tumors Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Antibody-drug Conjugates for Tumors Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Antibody-drug Conjugates for Tumors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Antibody-drug Conjugates for Tumors by Type (2019-2030)
Figure 52. Global Revenue Market Share of Antibody-drug Conjugates for Tumors by Type (2019-2030)
Figure 53. Global Antibody-drug Conjugates for Tumors Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Antibody-drug Conjugates for Tumors by Application (2019-2030)
Figure 55. Global Revenue Market Share of Antibody-drug Conjugates for Tumors by Application (2019-2030)
Figure 56. Global Antibody-drug Conjugates for Tumors Price (US$/Unit) by Application (2019-2030)
Figure 57. Antibody-drug Conjugates for Tumors Value Chain
Figure 58. Antibody-drug Conjugates for Tumors Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
